Chris Vindurampulle is a senior associate with the intellectual property team in the firm's Melbourne office.
Chris' experience includes biotechnology, medical devices, pharmaceuticals, agri-technology, food products and processing, and simple mechanical technology.
Prior to joining the firm, Chris was a senior associate at a boutique IP firm where he helped clients protect and leverage their intellectual property rights to achieve commercial success. Chris' focus has been broadly in life sciences.
Following his PhD, Chris was a postdoctoral research scientist where he developed and patented two key technologies related to vaccines.
- Inventor listed on granted U.S. Patents US 8,137,930 and US 8,076,130, and other corresponding foreign applications which are pending. US 8,137,930 has been the subject of a licensing agreement with an Indian biotech company.
- Employed as a researcher on two Bill and Melinda Gates funded Grand Challenges in Global Health initiatives.
- Author listed in nine scientific journal articles.
- Institute of Patent and Trademark Attorneys (Ordinary)